Patent · US Active

2-aminoindole compounds and methods for the treatment of malaria

US8980926B2 · kind B2 · utility

0Cited by

9References

12Claims

0Family size

Assignees

Genzyme Corporation · US
President and Fellows of Harvard College · US
Massachusetts Institute of Technology · US

Inventors

Ralph Mazitschek · Belmont, US
Jon Clardy · Ithaca, US
Dyann F. Wirth · Boston, US
Roger C. Wiegand · Chesterfield, US
Sameer Urgaonkar · Amherst, US
Mary Lynn Baniecki · Cambridge, US
Joseph Cortese · Quincy, US
Cassandra Celatka · Hull, US
Yibin Xiang · Dracut, US
Renato Skerlj · Vancouver, CA
Elyse Bourque · Langley, CA

Key dates

Filing date	Oct 28, 2010
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Oct 28, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods of treating a subject with malaria comprising administering a 2-aminoindole compound represented by Formula: (I)—The values and preferred values of the variables in Structural Formula I are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.